Sarv Bio Pharma Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 26-10-2024
- Paid Up Capital ₹ 2.62 Cr
as on 26-10-2024
- Company Age 4 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.61 Cr
as on 26-10-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 0.09%
(FY 2023)
About Sarv Bio Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 2.62 Cr.
The company currently has active open charges totaling ₹32.61 Cr.
Akshay Bansal, Ajay Bansal, Vijay Aggarwal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24297PB2020PTC052402
- Company No.
052402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarv Bio Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Bansal  | Director | 05-Dec-2020 | Current |
| Akshay Bansal | Director | 05-Dec-2020 | Current |
| Vijay Aggarwal | Director | 05-Dec-2020 | Current |
| Nitin Aggarwal | Director | 05-Dec-2020 | Current |
| Anirudh Aggarwal | Director | 05-Dec-2020 | Current |
Financial Performance of Sarv Bio Pharma.
Sarv Bio Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sarv Bio Pharma?
In 2023, Sarv Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarv Bio Labs Private LimitedActive 19 years 11 monthsAkshay Bansal, Ajay Bansal and 3 more are mutual person
- Ecogenics Solutions Private LimitedActive 5 years 1 month
Vijay Aggarwal and Anirudh Aggarwal are mutual person
- Jai Ambey Containers Private LimitedActive 25 years 10 months
Vijay Aggarwal and Anirudh Aggarwal are mutual person
- Sarv Bio Pharmaceutical Research Private LimitedActive 3 years 11 months
Vijay Aggarwal and Anirudh Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Oct 2021 | ₹32.61 Cr | Open |
How Many Employees Work at Sarv Bio Pharma?
Sarv Bio Pharma has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarv Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarv Bio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
